Interleukin family member ST2 and mortality in acute dyspnoea
Journal of Internal Medicine, 11/12/2010
Socrates T et al. – In patients presenting to the ED with acute dyspnoea, ST2 is a strong and independent predictor of 30–day and 1–year mortality and might improve risk stratification already provided by B–type natriuretic peptide (BNP) or NT–proBNP.



